Navigation Links
Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors

This release is available in German.

The Orthopedic Clinic and Policlinic at the University Medical Center of Johannes Gutenberg University Mainz (JGU) has recently deployed a new system for the treatment of spinal tumors for the first time. This treatment is a combination of the so-called radiofrequency ablation, which uses the heat energy of radio frequency waves to ablate and destroy tumors, and a subsequent kyphoplasty, by which the spine is stabilized through the injection of bone cement as filler material. A recently started single-center study involving 10 evaluable patients suffering from painful metastatic spinal tumors is now expected to provide information about the efficacy of this method.

"The results of this trial will provide critical information about the safety and efficacy of minimally invasive targeted radiofrequency ablation to treat vertebral metastates," says Professor Dr med Andreas Kurth, Director of the Orthopedic Clinic at the University Medical Center of Johannes Gutenberg University Mainz. "We are confident that this advanced method employed for tumor reduction and simultaneous stabilization of the spine through bone-sparing kyphoplasty will minimize the cancer patient's severe discomfort while stabilizing the vertebra."

The Spinal Tumor Ablation with Radiofrequency (STAR)TM System of DFINE, Inc., which was jointly developed with the Orthopedic Clinic of Mainz University Medical Center, is already FDA-approved as a device permitting minimally invasive targeted tumor necrosis of metastatic spinal tumors. Following ablation with the STAR System, vertebra(e) will be stabilized with ultra-high viscosity cement. This minimally invasive procedure generally takes about an hour. The data to be perceived from the Evaluation of Combined RF Ablation and Cement Delivery in Painful Tumors of the Spine Trial (AbCT) are to support the filing for Conformit Europenne (CE) Mark certification in 2012.

In the United States alone, 13 percent (190,000 cases) of the 1.5 million new cancer cases diagnosed annually will develop spinal mestasis. Beyond narcotic administration and traditional pain management, the primary modality for treating spinal metastases is external beam radiation. While this represents the current standard of care for treating metastatic cancer, pain relief often requires multiple treatments and weeks to be effective. In addition, radiation therapy often requires that patients suspend chemotherapy treatment of the primary cancer due to cumulative toxicity. Using the DFINE minimally invasive procedure to treat painful metastatic spinal lesions provides immediate pain relief and an improved quality of life. There is also minimal, if any, delay in systemic, curative therapy of the primary cancer therapy - a significant benefit for the patient.

The STARTM System of DFINE incorporates a unique bipolar navigational instrument, which offers unparalleled control and enables the physician to overcome many of the technical challenges which have limited targeted ablation in boney tissues to date. "Due to the critical anatomy in the spine and the invasive nature of conventional surgical procedures to treat spinal metastases, we believe DFINE's minimally invasive therapy that allows targeted delivery of radiofrequency energy for ablation of tumors may provide the fastest and most effective relief from the painful effects of spinal metastases, and thereby represents a significant advance in the patient's treatment," states Kurth.


Contact: Dr. Renee Dillinger-Reiter
Johannes Gutenberg Universitaet Mainz

Related medicine news :

1. Wayne State University researcher argues that sex reduces genetic variation
2. New book by Indiana University physicians slays health myths we all thought were true
3. Health providers should emphasize breast cancer screening, Wayne State University research finds
4. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
5. Religion benefits traumatic brain injury victims, Wayne State University research finds
6. Internationally recognized BME professor to join University of Texas as visiting scholar
7. Three senior Hebrew University faculty members receive Kaye Awards for innovations
8. Wayne State University researchers win grant from the NSF to target tinnitus
9. Black heart attack patients wait longer for advanced treatment, University of Michigan study shows
10. University of Louisville surgeons perform first prosthetic bypass graft with patients stem cells at point-of-care
11. Boston University School of Medicine professor honored by the Endocrine Society
Post Your Comments:
(Date:10/13/2017)... ... 2017 , ... While it’s often important to take certain medications during the ... Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL ... it eliminates the need to turn on a light when taking medication during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of ... part of a disaster drill on October 3rd. , Apple Rehab participated with the ... as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology: